These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31004738)

  • 21. KDELR2 Promotes Glioblastoma Tumorigenesis Targeted by HIF1a via mTOR Signaling Pathway.
    Liao Z; She C; Ma L; Sun Z; Li P; Zhang X; Wang P; Li W
    Cell Mol Neurobiol; 2019 Nov; 39(8):1207-1215. PubMed ID: 31342232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
    Han LL; Jia L; Wu F; Huang C
    Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity.
    Hu JQ; Deng F; Hu XP; Zhang W; Zeng XC; Tian XF
    Oncol Rep; 2018 Dec; 40(6):3635-3644. PubMed ID: 30542728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance.
    Chang M; Qiao L; Li B; Wang J; Zhang G; Shi W; Liu Z; Gu N; Di Z; Wang X; Tian Y
    Oncol Rep; 2017 Aug; 38(2):1251-1258. PubMed ID: 28677777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α-Hederin inhibits the growth of lung cancer A549 cells
    Fang C; Liu Y; Chen L; Luo Y; Cui Y; Zhang N; Liu P; Zhou M; Xie Y
    Pharm Biol; 2021 Dec; 59(1):11-20. PubMed ID: 33356727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIRT6 suppresses glioma cell growth via induction of apoptosis, inhibition of oxidative stress and suppression of JAK2/STAT3 signaling pathway activation.
    Feng J; Yan PF; Zhao HY; Zhang FC; Zhao WH; Feng M
    Oncol Rep; 2016 Mar; 35(3):1395-402. PubMed ID: 26648570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor.
    Wang Z; Zhang S; Siu TL; Huang S
    Curr Pharm Des; 2015; 21(10):1268-71. PubMed ID: 25506897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma.
    Li J; Zhu S; Tong J; Hao H; Yang J; Liu Z; Wang Y
    Neuroreport; 2016 Jan; 27(2):110-5. PubMed ID: 26694942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
    Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
    Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
    Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
    Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
    Bai Y; Zhang QG; Wang XH
    Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells.
    Cheng Q; Ma X; Cao H; Chen Z; Wan X; Chen R; Peng R; Huang J; Jiang B
    Mol Med Rep; 2017 Feb; 15(2):597-604. PubMed ID: 28035389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma.
    Zeng A; Yin J; Li Y; Li R; Wang Z; Zhou X; Jin X; Shen F; Yan W; You Y
    Cell Death Dis; 2018 Mar; 9(3):394. PubMed ID: 29531296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase SIRT6 inhibits glioma cell growth through down-regulating NOTCH3 expression.
    Chen X; Li D; Gao Y; Cao Y; Hao B
    Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):417-424. PubMed ID: 29659670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
    Xu X; Zhang F; Chen X; Ying Q
    Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
    Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
    Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GNA13 inhibits glioblastoma metastasis via the ERKs/FOXO3 signaling pathway.
    Yi Q; Huang M; Zhang X; Xu Z; Sun J; Wang S; Xu H; Du Z; Liu M
    Cell Signal; 2023 Sep; 109():110789. PubMed ID: 37392861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.